Innovative Medicines Initiative

IMI2 - Call 14

Deadline: June 14, 2018

In this call, IMI presents the following four topics: 

  • Topic 1: Targeted immune intervention for the management of non-response and relapse
  • Topic 2: Non-invasive clinical molecular imaging of immune cells
  • Topic 3: Development of a platform for federated and privacy-preserving machine learning in support of drug discovery 
  • Topic 4: Centre of excellence – remote decentralised clinical trials 

Stage 1 submission deadline: 14 June 2018. Stage 2 submission deadline: 11 December 2018.

Funds projects within:

The official call from Innovative Medicines Initiative

Can your project get funding from Innovative Medicines Initiative

Is this call a perfect match for your project? Contact us to discuss your possibilities within Innovative Medicines Initiative.

All calls from Innovative Medicines Initiative

About Innovative Medicines Initiative

With support from the Innovative Medicines Initiative, you will be able to conduct international research for the development of medical products. IMI is working to improve health by speeding up the development of, and patient access to, innovative medicines, particularly in areas where there is an unmet medical or social need. 

More about the grant

We help you succeed

We help companies obtain public funding by converting good projects to well-prepared applications.

Our services cover the entire application process:

Identifying funding opportunities
We identifying your best funding opportunities
Planning and scoping your project
We plan and scope your project to meet demands
Writing the successful application
We write the application that increases your chance of success